HighTide Therapeutics, Ltd. | WebDisclosure

Basculer en Français

9904	Companies
199533	Keywords
130386	Articles
106040	Press releases

Headlines Articles Press releases HighTide Therapeutics, Ltd.

Home
Companies
HighTide Therapeutics, Ltd.

BRIEF

published on 06/07/2024 at 19:00, 1 year 8 months ago

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at 2024 International Liver Congress

Clinical Study MASH HighTide Therapeutics T2DM HTD1801
BRIEF

published on 06/07/2024 at 19:00, 1 year 8 months ago

HighTide Therapeutics présente les analyses de l'étude MASH de phase 2a au Congrès international du foie 2024

Étude Clinique PURÉE HTD1801 Thérapeutique HighTide DT2
PRESS RELEASE

published on 06/07/2024 at 18:55, 1 year 8 months ago

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate...
HighTide Therapeutics presents analyses of Phase 2a MASH Study at the 2024 International Liver Congress, reinforcing and characterizing the efficacy and safety of Berberine Ursodeoxycholate

Safety HighTide Therapeutics Phase 2a MASH Study Berberine Ursodeoxycholate Efficacy

Accesswire

Published on 02/20/2026 at 18:30, 13 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 2 hours 58 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 13 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 35 minutes ago

Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 43 minutes ago

Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE

EQS Group

Published on 02/20/2026 at 18:36, 7 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 12 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 20 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 43 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 43 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

Les Echos

Published on 02/20/2026 at 18:00, 43 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 43 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 hour 8 minutes ago

CHIFFRE D'AFFAIRES 2025
Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE